BDBM37521 2-[5-(4-Fluoro-phenyl)-1-methyl-1H-imidazol-2-ylsulfanyl]-N-(2-morpholin-4-yl-phenyl)-acetamide::2-[5-(4-fluorophenyl)-1-methyl-imidazol-2-yl]sulfanyl-N-(2-morpholin-4-ylphenyl)ethanamide::2-[5-(4-fluorophenyl)-1-methylimidazol-2-yl]sulfanyl-N-(2-morpholin-4-ylphenyl)acetamide::2-[[5-(4-fluorophenyl)-1-methyl-2-imidazolyl]thio]-N-[2-(4-morpholinyl)phenyl]acetamide::2-[[5-(4-fluorophenyl)-1-methyl-imidazol-2-yl]thio]-N-(2-morpholinophenyl)acetamide::MLS000034070::SMR000005285::cid_647688
SMILES Cn1c(SCC(=O)Nc2ccccc2N2CCOCC2)ncc1-c1ccc(F)cc1
InChI Key InChIKey=MLIMTXWCEUAIBR-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37521
TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair